{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:39:15Z","timestamp":1775104755730,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Chongqing, China","award":["CSTB2022NSCQ-MSX1207"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX1207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04792-7","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:44:05Z","timestamp":1763019845000},"page":"5891-5902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-associated hypertensive crisis: a disproportionality analysis of the FAERS database"],"prefix":"10.1007","volume":"399","author":[{"given":"Chunyong","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"1","key":"4792_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccl.2005.09.002","volume":"24","author":"M Aggarwal","year":"2006","unstructured":"Aggarwal M, Khan IA (2006) Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin 24(1):135\u2013146","journal-title":"Cardiol Clin"},{"issue":"10","key":"4792_CR2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/17512433.2017.1366311","volume":"10","author":"O Alfarisi","year":"2017","unstructured":"Alfarisi O, Alghamdi WA, Al-Shaer MH, Dooley KE, Peloquin CA (2017) Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis? Expert Rev Clin Pharmacol 10(10):1027\u20131036","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"4792_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.medcli.2017.09.027","volume":"150","author":"G Arbe","year":"2018","unstructured":"Arbe G, Pastor I, Franco J (2018) Diagnostic and therapeutic approach to the hypertensive crisis. Med Clin (Barc) 150(8):317\u2013322","journal-title":"Med Clin (Barc)"},{"key":"4792_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.704281","volume":"8","author":"A Calvi","year":"2021","unstructured":"Calvi A, Fischetti I, Verzicco I, Belvederi Murri M, Zanetidou S, Volpi R, Coghi P, Tedeschi S, Amore M, Cabassi A (2021) Antidepressant drugs effects on blood pressure. Front Cardiovasc Med 8:704281","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"4792_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s13105-021-00864-3","volume":"78","author":"C Carp\u00e9n\u00e9","year":"2022","unstructured":"Carp\u00e9n\u00e9 C, Les F, Mercader-Barcel\u00f3 J, Boulet N, Briot A, Grolleau JL (2022) High doses of tyramine stimulate glucose transport in human fat cells. J Physiol Biochem 78(2):543\u2013556","journal-title":"J Physiol Biochem"},{"issue":"19","key":"4792_CR6","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560\u20132572","journal-title":"JAMA"},{"key":"4792_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.941079","volume":"12","author":"C Cui","year":"2022","unstructured":"Cui C, Deng L, Wang W et al (2022) Respiratory system toxicity induced by immune checkpoint inhibitors: a real-world study based on the FDA adverse event reporting system database. Front Oncol 12:941079","journal-title":"Front Oncol"},{"issue":"10","key":"4792_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1524-6175.2004.03608.x","volume":"6","author":"WJ Elliott","year":"2004","unstructured":"Elliott WJ (2004) Clinical features and management of selected hypertensive emergencies. J Clin Hypertens (Greenwich) 6(10):587\u2013592","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"16","key":"4792_CR9","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1055\/s-0043-111739","volume":"142","author":"RW Freudenmann","year":"2017","unstructured":"Freudenmann RW, Freudenmann N, Zurowski B, Sch\u00f6nfeldt-Lecuona C, Maier L, Schmieder RE, Lange-Asschenfeldt C, Gahr M (2017) Arterielle Hyper- und Hypotonie assoziiert mit Psychopharmaka: eine Risikobewertung basierend auf den Fachinformationen [Arterial Hyper- and Hypotension associated with psychiatric medications: a risk assessment based on the summaries of product characteristics (SmPCs)]. Dtsch Med Wochenschr 142(16):e100\u2013e107","journal-title":"Dtsch Med Wochenschr"},{"issue":"3","key":"4792_CR10","volume":"3","author":"D Gnjidic","year":"2025","unstructured":"Gnjidic D, Langford AV, Jordan V, Sawan M, Sheppard JP, Thompson W, Todd A, Hopper I, Hilmer SN, Reeve E (2025) Withdrawal of antihypertensive drugs in older people. Cochrane Database Syst Rev 3(3):CD012572","journal-title":"Cochrane Database Syst Rev"},{"key":"4792_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102176","volume":"33","author":"C G\u00f3mez","year":"2021","unstructured":"G\u00f3mez C, Cobos P, Alberdi E (2021) Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up. Photodiagnosis Photodyn Ther 33:102176","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"3","key":"4792_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ahj.2010.06.032","volume":"160","author":"JM Gore","year":"2010","unstructured":"Gore JM, Peterson E, Amin A, Anderson FA Jr, Dasta JF, Levy PD, O\u2019Neil BJ, Sung GY, Varon J, Wyman A, Granger CB, STAT Investigators (2010) Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational studying the treatment of acute hypertension (STAT) study. Am Heart J 160(3):521-527.e1","journal-title":"Am Heart J"},{"issue":"1","key":"4792_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s13555-019-00341-2","volume":"10","author":"E Grace","year":"2020","unstructured":"Grace E, Goldblum O, Renda L et al (2020) Injection site reactions in the Federal Adverse Event Reporting System (FAERS) post-marketing database vary among biologics approved to treat moderate-to-severe psoriasis. Dermatol Ther (Heidelb) 10(1):99\u2013106","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"Pt A","key":"4792_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2015.06.027","volume":"763","author":"A Grossman","year":"2015","unstructured":"Grossman A, Messerli FH, Grossman E (2015) Drug induced hypertension\u2013an unappreciated cause of secondary hypertension. Eur J Pharmacol 763(Pt A):15\u201322","journal-title":"Eur J Pharmacol"},{"key":"4792_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1278442","volume":"15","author":"W He","year":"2024","unstructured":"He W, Wang Y, Chen K (2024) A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam. Front Pharmacol 15:1278442","journal-title":"Front Pharmacol"},{"issue":"4","key":"4792_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/HCO.0000000000000398","volume":"32","author":"E Ipek","year":"2017","unstructured":"Ipek E, Oktay AA, Krim SR (2017) Hypertensive crisis: an update on clinical approach and management. Curr Opin Cardiol 32(4):397\u2013406","journal-title":"Curr Opin Cardiol"},{"issue":"12","key":"4792_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004511","volume":"5","author":"AT Janke","year":"2016","unstructured":"Janke AT, McNaughton CD, Brody AM, Welch RD, Levy PD (2016) Trends in the incidence of hypertensive emergencies in US emergency departments from 2006 to 2013. J Am Heart Assoc 5(12):e004511","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"4792_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.108.126698","volume":"53","author":"CM Licht","year":"2009","unstructured":"Licht CM, de Geus EJ, Seldenrijk A, van Hout HP, Zitman FG, van Dyck R, Penninx BW (2009) Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 53(4):631\u2013638","journal-title":"Hypertension"},{"issue":"5","key":"4792_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0736-z","volume":"19","author":"AR Lovell","year":"2017","unstructured":"Lovell AR, Ernst ME (2017) Drug-induced hypertension: focus on mechanisms and management. Curr Hypertens Rep 19(5):39","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"4792_CR20","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1378\/chest.06-2490","volume":"131","author":"PE Marik","year":"2007","unstructured":"Marik PE, Varon J (2007) Hypertensive crises: challenges and management. Chest 131(6):1949\u20131962","journal-title":"Chest"},{"issue":"1","key":"4792_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3909-z","volume":"20","author":"VM Martins","year":"2019","unstructured":"Martins VM, Helal L, Ferrari F, Bottino LG, Fuchs SC, Fuchs FD (2019) Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial. Trials 20(1):736","journal-title":"Trials"},{"issue":"11","key":"4792_CR22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.amjcard.2015.09.007","volume":"116","author":"CD McNaughton","year":"2015","unstructured":"McNaughton CD, Self WH, Zhu Y, Janke AT, Storrow AB, Levy P (2015) Incidence of hypertension-related emergency department visits in the United States, 2006 to 2012. Am J Cardiol 116(11):1717\u20131723","journal-title":"Am J Cardiol"},{"issue":"4","key":"4792_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093542","volume":"9","author":"G Pinna","year":"2014","unstructured":"Pinna G, Pascale C, Fornengo P, Arras S, Piras C, Panzarasa P, Carmosino G, Franza O, Semeraro V, Lenti S, Pietrelli S, Panzone S, Bracco C, Fiorini R, Rastelli G, Bergandi D, Zampaglione B, Musso R, Marengo C, Santoro G, Zamboni S, Traversa B, Barattini M, Bruno G (2014) Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study. PLoS One 9(4):e93542","journal-title":"PLoS One"},{"issue":"2","key":"4792_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/CRD.0b013e3181c307b7","volume":"18","author":"MA Rodriguez","year":"2010","unstructured":"Rodriguez MA, Kumar SK, De Caro M (2010) Hypertensive crisis. Cardiol Rev 18(2):102\u2013107","journal-title":"Cardiol Rev"},{"issue":"6","key":"4792_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12012-018-9476-9","volume":"18","author":"M Salter","year":"2018","unstructured":"Salter M, Kenney A (2018) Myocardial injury from tranylcypromine-induced hypertensive crisis secondary to excessive tyramine intake. Cardiovasc Toxicol 18(6):583\u2013586","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"4792_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/tri.12881","volume":"30","author":"J Simkins","year":"2017","unstructured":"Simkins J, Morris MI, Abbo LM, Camargo JF (2017) Severe hypertension after initiation of rifapentine\/isoniazid for latent tuberculosis in renal transplant candidates. Transpl Int 30(1):108\u2013109","journal-title":"Transpl Int"},{"issue":"11","key":"4792_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1345\/aph.18450","volume":"33","author":"ME Temple","year":"1999","unstructured":"Temple ME, Nahata MC (1999) Rifapentine: its role in the treatment of tuberculosis. Ann Pharmacother 33(11):1203\u20131210","journal-title":"Ann Pharmacother"},{"issue":"5","key":"4792_CR28","first-page":"248","volume":"69","author":"BJ van den Born","year":"2011","unstructured":"van den Born BJ, Beutler JJ, Gaillard CA, de Gooijer A, van den Meiracker AH, Kroon AA (2011) Dutch guideline for the management of hypertensive crisis \u2013 2010 revision. Neth J Med 69(5):248\u2013255","journal-title":"Neth J Med"},{"issue":"3","key":"4792_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/00003495-200868030-00003","volume":"68","author":"J Varon","year":"2008","unstructured":"Varon J (2008) Treatment of acute severe hypertension: current and newer agents. Drugs 68(3):283\u2013297","journal-title":"Drugs"},{"issue":"1","key":"4792_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1378\/chest.118.1.214","volume":"118","author":"J Varon","year":"2000","unstructured":"Varon J, Marik PE (2000) The diagnosis and management of hypertensive crises. Chest 118(1):214\u2013227","journal-title":"Chest"},{"key":"4792_CR31","doi-asserted-by":"crossref","unstructured":"Vuylsteke A, Vincent JL, de La Garanderie DP, Anderson FA, Emery L, Wyman A, Rushton-Smith S, Gore JM; Euro-STAT Investigators (2011) Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT). Crit Care 15(6):R271.","DOI":"10.1186\/cc10551"},{"issue":"1","key":"4792_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jch.13448","volume":"21","author":"M Wallbach","year":"2019","unstructured":"Wallbach M, Lach N, Stock J, Hiller H, Mavropoulou E, Chavanon ML, Neurath H, Blaschke S, Lowin E, Herrmann-Lingen C, M\u00fcller GA, Koziolek MJ (2019) Direct assessment of adherence and drug interactions in patients with hypertensive crisis-a cross-sectional study in the emergency department. J Clin Hypertens (Greenwich) 21(1):55\u201363","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"4792_CR33","volume":"8","author":"S Xu","year":"2024","unstructured":"Xu S, Cobzaru R, Finkelstein SN, Welsch RE, Ng K, Middleton L (2024) Foundational model aided automatic high-throughput drug screening using self-controlled cohort study. medRxiv 8(4):24311480","journal-title":"medRxiv"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04792-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04792-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04792-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:12:57Z","timestamp":1775099577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04792-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4792"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04792-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The FAERS database contains anonymized patient information. The Hospital Ethics Committee has confirmed that no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}